Twyla Briley is a seasoned management consultant with extensive experience working closely with senior leaders to develop and implement strategy and orchestrate major organizational change initiatives. Twyla is an expert at creating frameworks and analyses to identify and resolve operational issues, and her background in change management ensures lasting success. Beyond the consulting hard skills, Twyla is known for her unique ability to provide cross-functional leadership across levels of the organization to align clients around problems and solutions. Her collaborative style makes her a sought-after consultant to drive resolution of difficult organizational issues.
Twyla began her consulting career with the Boston Consulting Group in 1996 and has since consulted independently and with LAACMA Consulting. She specializes in the pharmaceutical, medical device and biotech industries. Twyla has extensive experience with growth companies and in organizational change following mergers and acquisitions. Prior to consulting Twyla worked as a Medical Device Engineer and a Market Research Associate also in the Medical Device arena.
Select experiences from Twyla’s career include:
Advised new Chief Medical Officer in the development of the organizational change agenda for a 600-person development organization. Project-managed redesign of the organization structure, processes, roles and responsibilities.
Facilitated a team of senior R&D executives from medical device and pharmaceutical business units to collaboratively identify and analyze cross-business savings opportunities. Developed the integration strategy to leverage resources across divisions. Eliminated 3% from the cost base.
Led consulting team to assess and design processes and structure to optimize resource use and timelines for the Chemistry Manufacturing and Controls organization of a Global pharmaceutical company; savings over $2M annually and productivity gains over 10% across various groups
Supported small Biotech company in the creation of their cross-functional development process to improve probability of success of the overall portfolio. Developed governance process, stage gates, and team structure to improve earlier identification of unproductive compounds.
Led consulting team to evaluate the financial implications of a potential pharmaceutical merger. Analyzed synergies, cost savings and market impact based on publicly available information.
Twyla has a BS in Mechanical Engineering from Stanford University and an MBA from Stanford Graduate School of Business. She has lived and worked in Germany and England and speaks German & Italian.